drugset / Trial / NCT01667263

The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia

NCT01667263

RandomizedParallel-groupOpen-labelTreatment

Summary

Randomized, open-label, multicentre study to compare the efficacy and safety of ATRA plus danazol with danazol monotherapy in patients with corticosteroid-resistant/relapsed ITP.

Timeline

Start
2012-06-01
Primary completion
2016-07-01
Completion
2017-02-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Danazol Other / unclassified 200 mg Oral
Subject Tretinoin Small molecule 10 mg Oral